Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug repurposing screen for the rare disease ataxia-telangiectasia.
Jayanth N, Mahé G, Campbell M, Lipkin M, Jain S, van de Bospoort R, Thornton J, Margus B, Fischer DF. Jayanth N, et al. Among authors: mahe g. SLAS Discov. 2024 Dec 4;30:100200. doi: 10.1016/j.slasd.2024.100200. Online ahead of print. SLAS Discov. 2024. PMID: 39638147 Free article.
Venous recanalisation in the setting of post-thrombotic syndrome: An expert consensus from the French Society of Vascular Medicine (SFMV) and the French Society of Cardiovascular Imaging and Interventional Radiology (SFICV).
Del Giudice C, Mahe G, Thony F, Zuily S, Goyault G, Diard A, Loffroy R, Galanaud JP, Thouveny F, Quere I, Menez C, Jurus C, Pernod G, Pernes JM, Sapoval M; Post-thrombotic syndrome study group of Interventional, Cardiovascular French Society of Radiology (SFICV), French Society of Vascular Medicine (SFMV). Del Giudice C, et al. Among authors: mahe g. J Med Vasc. 2024 Sep;49(3-4):141-161. doi: 10.1016/j.jdmv.2024.06.002. Epub 2024 Aug 27. J Med Vasc. 2024. PMID: 39278694 Free article.
In-silico trial emulation to predict the cardiovascular protection of new lipid-lowering drugs: an illustration through the design of the SIRIUS programme.
Angoulvant D, Granjeon-Noriot S, Amarenco P, Bastien A, Bechet E, Boccara F, Boissel JP, Cariou B, Courcelles E, Diatchenko A, Filipovics A, Kahoul R, Mahé G, Peyronnet E, Portal L, Porte S, Wang Y, Steg PG. Angoulvant D, et al. Among authors: mahe g. Eur J Prev Cardiol. 2024 Nov 11;31(15):1820-1830. doi: 10.1093/eurjpc/zwae254. Eur J Prev Cardiol. 2024. PMID: 39101472
Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study.
Gouin-Thibault I, Mansour A, Caribotti C, Pierre-Jean M, Bouzille G, Ballerie A, Maucorps L, Gueret P, Nédelec-Gac F, Pontis A, Mahé G, Vannier S, Behar N, Cardiet I, Mismetti P, Frouget T, Delavenne X. Gouin-Thibault I, et al. Among authors: mahe g. J Thromb Haemost. 2024 Oct;22(10):2864-2872. doi: 10.1016/j.jtha.2024.07.006. Epub 2024 Jul 15. J Thromb Haemost. 2024. PMID: 39019439
244 results